Southern blot analysis of the dCK genomic region of patients with resistant AML.

Genomic DNA from PHA T cells from a healthy donor and unpurified BM cells from 3 patients with resistant AML were digested withEcoRI, HindIII, and EcoRI plusHindIII. Lane 1, PHA T cells from a healthy donor; lane 2, unpurified leukemic blasts from patient rAML3; lane 3, unpurified leukemic blasts from rAML12; and lane 4, unpurified leukemic blasts from rAML2.